Glycemic Index testing of Celevida

Not Applicable

• Registration Number: CTRI/2021/11/037861
• Lead Sponsor: Madras Diabetes Research Foundation

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 21 February 2022

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

•BMI <= 22.9 kg/ m2

•Both male and female

•Willingness to consume the test foods

•no known food allergy or intolerance;

•no medications known to affect glucose tolerance (excluding oral contraceptives) â?? stable doses of oral contraceptives, acetylsalicylic acid, thyroxin, vitamins and mineral supplements or drugs to treat hypertension or osteoporosis are acceptable.

Exclusion Criteria

•a known history of diabetes mellitus or the use of anti-hyperglycemic drugs or insulin to treat diabetes and related conditions

•pregnant or lactating women

• a major medical or surgical event requiring hospitalization within the preceding 3 months;

•the presence of disease or drug(s) which influence digestion and absorption of nutrients;

•the use of steroids, protease inhibitors or antipsychotics (all of which have major effects on glucose metabolism and body fat distribution).

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The glycemic index, GI category of food productsTimepoint: 3-6 months

Secondary Outcome Measures

Name	Time	Method
ilTimepoint: NA